Pediatrix Medical Group Inc (MD)

Currency in USD
26.34
-0.27(-1.01%)
Closed·
26.340.00(0.00%)
·
MD is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
25.8726.64
52 wk Range
15.7027.94
Key Statistics
Prev. Close
26.61
Open
26.39
Day's Range
25.87-26.64
52 wk Range
15.7-27.94
Volume
559.23K
Average Volume (3m)
792.81K
1-Year Change
64.2145%
Book Value / Share
10.99
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MD Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
26.17
Downside
-0.66%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Analyst Ratings

2 Buy
5 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 26.17
(-0.66% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Truist Securities
Hold28.00+6.30%23.00MaintainJul 14, 2026
UBS
Hold25.00-5.09%22.00MaintainMay 12, 2026
Mizuho
Hold24.00-8.88%21.00MaintainMay 08, 2026
Jefferies
Buy27.00+2.51%24.00MaintainApr 20, 2026
Truist Securities
Hold23.00-12.68%21.00MaintainApr 13, 2026

Pediatrix Medical Group Inc Earnings Call Summary for Q2/2026

  • Pediatrix Q2 2026 EPS of $0.63 beat estimates of $0.60; revenue of $488M topped forecast of $478.49M, but shares fell 1.1% to $25.96.
  • Same-unit pricing rose 4% on stronger collections and payer mix; volumes declined 2% due to seasonal patterns, expected flat to down for full year.
  • Company reaffirmed full-year 2026 adjusted EBITDA guidance of $280M-$300M with 'fairly ratable' Q3-Q4 earnings expected.
  • Management warned RCM collections tailwind will fade in H2 2026; G&A rising to $230M-$240M due to one-time executive transition costs.
  • Expanding tele-hybrid care model beyond core services; continues share buybacks and evaluating M&A in women's and children's medicine.
Last Updated: 08/04/2026, 10:24 PM
Read Full Transcript

Earnings

Latest Release
Aug 04, 2026
EPS / Forecast
0.63 / 0.60
Revenue / Forecast
488M / 478.49M
EPS Revisions
Last 90 days

MD Income Statement

Compare MD to Peers and Sector

Metrics to compare
MD
Peers
Sector
Relationship
P/E Ratio
12.1x20.1x−0.4x
PEG Ratio
0.191.020.00
Price/Book
2.4x3.8x2.6x
Price / LTM Sales
1.1x1.2x3.1x
Upside (Analyst Target)
4.1%21.5%47.9%
Fair Value Upside
Unlock0.3%6.3%Unlock

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
49.71M62.67%1.32B
Other Institutional Investors
37.33M37.33%993.32M
Public Companies & Retail Investors
0.000.00%0.00
Total
87.04M100.00%2.32B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.17.29%13,714,275364,937
Vanguard Portfolio Management, LLC7.76%6,154,126163,761

People Also Watch

139.70
PODD
-2.54%
203.06
MOH
-4.41%
64.41
CNC
-4.54%
72.97
ZTS
-1.11%

FAQ

What Is the Pediatrix Medical (MD) Stock Price Today?

The Pediatrix Medical stock price today is 26.34 USD.

What Stock Exchange Does Pediatrix Medical Trade On?

Pediatrix Medical is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Pediatrix Medical?

The stock symbol for Pediatrix Medical is "MD."

What Is the Pediatrix Medical Market Cap?

As of today, Pediatrix Medical market cap is 2.11B USD.

What Is Pediatrix Medical's Earnings Per Share (TTM)?

The Pediatrix Medical EPS (TTM) is 2.10.

When Is the Next Pediatrix Medical Earnings Date?

Pediatrix Medical will release its next earnings report on Oct 29, 2026.

From a Technical Analysis Perspective, Is MD a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Pediatrix Medical Stock Split?

Pediatrix Medical has split 2 times.

How Many Employees Does Pediatrix Medical Have?

Pediatrix Medical has 4280 employees.

What is the current trading status of Pediatrix Medical (MD)?

As of Aug 17, 2026, Pediatrix Medical (MD) is trading at a price of 26.34 USD, with a previous close of 26.61 USD. The stock has fluctuated within a day range of 25.87 USD to 26.64 USD, while its 52-week range spans from 15.70 USD to 27.94 USD.

What Is Pediatrix Medical (MD) Price Target According to Analysts?

The average 12-month price target for Pediatrix Medical is 26.17 USD, with a high estimate of 28 USD and a low estimate of 21 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an -0.66% Downside potential.

What Is the MD Premarket Price?

MD's last pre-market stock price is 26.46 USD. The pre-market share volume is 1,960.00, and the stock has decreased by -0.15, or -0.56%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.